|
Jan. 27, 2025 |
|
|
Mar. 31, 2026 |
|
|
jRCT2011240068 |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer (SR0379-JP-SU-02) |
|
A Phase 3 Study of SR-0379 in Participants with Skin Ulcer (SR0379-JP-SU-02) |
Tomioka Hideki |
||
FunPep Co., Ltd. |
||
Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka |
||
+81-6-6369-7957 |
||
htomioka@funpep.co.jp |
||
Kasahara Satoru |
||
FunPep Co., Ltd. |
||
Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka |
||
+81-6-6369-7957 |
||
skasahara@funpep.co.jp |
Recruiting |
Mar. 01, 2025 |
||
| Mar. 18, 2025 | ||
| 142 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
Patients with a skin ulcer requiring wound bed preparation before surgical intervention (sutures, skin grafts or pedicle flaps) |
||
Patients with obvious infection at the ulcer site, such as redness or swelling around the ulcer, pus, foul odor, or fever |
||
| 18age old over | ||
| 85age old under | ||
Both |
||
skin ulcer |
||
SR-0379 or placebo spray |
||
Days to minor surgical intervention (sutures, skin grafts or pedicle flaps) |
||
| FunPep Co., Ltd. |
| Hakodate Central General Hospital Institutional Review Board | |
| 33-2, Hon-cho, Hakodate-city, Hokkaido, Hokkaido | |
+81-138-52-1231 |
|
| kubota-y@hakochu-hp.gr.jp | |
| Approval | |
Jan. 14, 2025 |
No |
none |